Article
N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Nov 2013
Pesch Beate, Gawrych Katarzyna, Rabstein Sylvia, Weiss Tobias, Casjens Swaantje, Rihs Hans-Peter, Ding Hui, Angerer Jürgen, Illig Thomas, Klopp Norman, Bueno-de-Mesquita Bas, Ros Martine M, Kaaks Rudolf, Chang-Claude Jenny, Roswall Nina, Tjønneland Anne, Overvad Kim, Clavel-Chapelon Françoise, Boutron-Ruault Marie-Christine, Dossus Laure, Boeing Heiner, Weikert Steffen, Trichopoulos Dimitrios, Palli Domenico, Sieri Sabina, Tumino Rosario, Panico Salvatore, Quirós José Ramón, González Carlos, Sánchez Mariá José, Dorronsoro Miren, Navarro Carmen, Barricarte Aurelio, Ljungberg Börje, Johansson Mattias, Ulmert David, Ehrnström Roy, Khaw Kay-Tee, Wareham Nick, Key Timothy J, Ferrari Pietro, Romieu Isabelle, Riboli Elio, Brüning Thomas, Vineis Paolo
Abstract excerpt
BACKGROUND: An association between N-acetyltransferase 2 (NAT2) slow acetylation and bladder cancer has been consistently observed in epidemiologic studies. However, evidence has been mainly derived from case-control studies and was sparse from cohort studies. We evaluated the association between NAT2 slow acetylation and bladder cancer in a case-control study nested in the European Prospective Investigation into...
Read the complete abstract on PubMed